TGFB1 and familial pancreatic carcinoma: Pirfenidone, an anti-fibrotic agent for idiopathic pulmonary fibrosis, inhibits CAF activation and proliferation in lung and pancreatic cancers by targeting TGF-β and reduces the production of fibrotic mediators secreted by CAFs [114,115,116,117].